Drug profile · INN
sodium thiosulfate
PEDMARQSI
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
sodium thiosulfate (PEDMARQSI) is an FDA-listed pharmaceutical active ingredient. Associated with FENNEC PHARMACEUTICALS INC.. Route of administration: injection. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12311026
Therapeutic uses for sodium thiosulfate formulations
granted -
US 11998604
Therapeutic uses for sodium thiosulfate formulations
granted -
US 11992530
Therapeutic uses for sodium thiosulfate and formulations
granted -
US 11964018
Therapeutic uses for sodium thiosulfate formulations
granted -
US 11617793
Anhydrous sodium thiosulfate and formulations thereof
granted -
US 11510984
Anhydrous sodium thiosulfate and formulations thereof
granted -
US 11291728
Anhydrous sodium thiosulfate and formulations thereof
granted -
US 10792363
Anhydrous sodium thiosulfate and formulations thereof
granted
Frequently asked questions
What is sodium thiosulfate?
sodium thiosulfate (PEDMARQSI) is an FDA-listed pharmaceutical active ingredient. Associated with FENNEC PHARMACEUTICALS INC.. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for sodium thiosulfate?
PEDMARQSI is a marketed brand name for sodium thiosulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sodium thiosulfate?
sodium thiosulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.